<DOC>
	<DOCNO>NCT00141661</DOCNO>
	<brief_summary>A 10-week safety tolerability study potential treatment mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>A Safety Tolerability Evaluation Two 10-Week Dose Regimens Orally-Administered PF-04494700 Alzheimer 's Patients</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probably Alzheimer 's disease least 1 year . Mini Mental State Exam ( MMSE ) score 1226 screening . Participants must receive cholinesterase inhibitor and/or memantine least 4 month , stable dose least 2 month . Current evidence neurological psychiatric illness could contribute dementia . Living alone . Poorly control high blood pressure .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Interventional , Alzheimer , Safety Tolerability</keyword>
</DOC>